The mRNA research team is involved in the design/development of mRNAs optimized for specific uses of vaccines and pharmaceuticals.

The DDS/adjuvant research team aims to design/develop DDS/adjuvants to achieve maximal performance of mRNA vaccines.

To evaluate vaccine efficacy and associated adverse reactions in animal models

To develop vaccines using effective epitopes

The virus analysis research team aims to construct diverse vaccine libraries based on the elucidated ecology of pathogenic viruses, including those responsible for priority infectious diseases.

To establish the research basis for developing safe and effective vaccines by determining the interactions between viral and host molecules

The genome analysis research team aims to elucidate the mechanisms underlying the onset and aggravation of infectious diseases from the perspective of genome analysis and identify factors that can contribute to the development of novel vaccines.

The clinical research team aims to conduct clinical trials for the human application of new vaccines discovered by research teams of the core vaccine development center, perform integrated analysis of clinical and specimen analysis data, and use vaccines with high clinical usefulness and reduced adverse reactions in clinical practice.

To achieve practical vaccine implementation, we conduct research and development for vaccine and new modality projects, as well as development up to the stage of licensing to companies.

Research on preparedness for and response to outbreaks, epidemics and pandemics with vaccine and immunization